QuiVad
My list

Home / Funds / GSA Capital Partners L.L.P.

GSA Capital Partners L.L.P.

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on GSA Capital Partners L.L.P. by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

381 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
April 12, 2018Innate PharmaFrance0.48%April 16, 2018
March 29, 2018DBV TechnologiesFrance0.90%May 30, 2019
March 23, 2018DBV TechnologiesFrance0.85%May 30, 2019
March 16, 2018DBV TechnologiesFrance0.90%May 30, 2019
March 13, 2018GenfitFrance0.49%March 15, 2018
March 8, 2018DBV TechnologiesFrance0.82%May 30, 2019
March 6, 2018GenfitFrance0.50%March 15, 2018
March 5, 2018Innate PharmaFrance0.58%April 16, 2018
February 28, 2018NanobiotixFrance0.48%March 2, 2018
February 19, 2018DBV TechnologiesFrance0.79%May 30, 2019
February 9, 2018Innate PharmaFrance0.69%April 16, 2018
February 1, 2018DBV TechnologiesFrance0.80%May 30, 2019
January 25, 2018Innate PharmaFrance0.70%April 16, 2018
January 23, 2018DBV TechnologiesFrance0.79%May 30, 2019
January 23, 2018NanobiotixFrance0.50%March 2, 2018
January 15, 2018Innate PharmaFrance0.61%April 16, 2018
January 9, 2018DBV TechnologiesFrance0.80%May 30, 2019
January 8, 2018Erytech PharmaFrance0.48%January 10, 2018
January 5, 2018Erytech PharmaFrance0.53%January 10, 2018
December 27, 2017Innate PharmaFrance0.50%April 16, 2018
December 22, 2017Innate PharmaFrance0.49%December 27, 2017
December 21, 2017Innate PharmaFrance0.71%December 27, 2017
December 19, 2017GenfitFrance0.48%December 21, 2017
December 15, 2017Erytech PharmaFrance0.68%January 10, 2018
December 14, 2017Erytech PharmaFrance0.70%January 10, 2018
December 11, 2017Erytech PharmaFrance0.68%January 10, 2018
December 8, 2017Innate PharmaFrance0.60%December 27, 2017
December 6, 2017Erytech PharmaFrance0.50%January 10, 2018
December 5, 2017DBV TechnologiesFrance0.77%May 30, 2019
November 23, 2017Innate PharmaFrance0.51%December 27, 2017
November 20, 2017DBV TechnologiesFrance0.80%May 30, 2019
November 14, 2017Erytech PharmaFrance0.35%November 16, 2017
November 13, 2017DBV TechnologiesFrance0.70%May 30, 2019
November 10, 2017Erytech PharmaFrance0.50%November 16, 2017
November 3, 2017DBV TechnologiesFrance0.60%May 30, 2019
November 3, 2017Innate PharmaFrance0.49%November 7, 2017
November 2, 2017DBV TechnologiesFrance0.56%May 30, 2019
October 31, 2017SRP GroupeFrance0.49%November 2, 2017
October 26, 2017SRP GroupeFrance0.52%November 2, 2017
October 25, 2017Innate PharmaFrance0.50%November 7, 2017
October 16, 2017GenfitFrance0.50%December 21, 2017
October 12, 2017PoxelFrance0.49%October 16, 2017
October 11, 2017LatecoereFrance0.49%October 13, 2017
October 2, 2017LatecoereFrance0.51%October 13, 2017
September 15, 2017CGGFrance0.46%September 19, 2017
September 12, 2017PoxelFrance0.59%October 16, 2017
September 4, 2017Innate PharmaFrance0.49%September 6, 2017
August 31, 2017Innate PharmaFrance0.51%September 6, 2017
August 17, 2017CGGFrance0.91%September 19, 2017
August 3, 2017CGGFrance0.82%September 19, 2017

Download 381 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners L.L.P., data as at October 27, 2021, https://www.quivad.com/detenteur/gsa-capital-partners-l-l-p?page=2